Wellington Management Group LLP 13D and 13G filings for UroGen Pharma Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2022-02-04 09:12 am Sale | 2021-12-31 | 13G | UroGen Pharma Ltd. URGN | Wellington Management Group LLP | 238,008 1.060% | -1,602,629![]() (-87.07%) | Filing |
2021-02-03 1:13 pm Purchase | 2020-12-31 | 13G | UroGen Pharma Ltd. URGN | Wellington Management Group LLP | 1,840,637 8.330% | 550,040![]() (+42.62%) | Filing |